ALLIGATOR BIOSCIENCE AB
33Patents
26Active
33Granted
49Portfolio score
Filing activity: Dec 12, 2000 → Nov 4, 2022 · 7 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9486520B2 | Compositions comprising polyglutamic acid nanoparticles and CD40 agonists | Human Necessities | 9 | Active |
| US9676862B2 | Anti-CD40 antibodies and methods of treating cancer | Chemistry; Metallurgy | 8 | Active |
| US10414815B2 | scFV antibody library | Chemistry; Metallurgy | 7 | Active |
| US6958213B2 | Method for in vitro molecular evolution of protein function | Chemistry; Metallurgy | 6 | Expired |
| US8303945B2 | Mutants of interleukin-1 receptor antagonist | Chemistry; Metallurgy | 5 | Active |
| US7153655B2 | Method for in vitro molecular evolution of protein function involving the use of exonuclease enzyme and two populations of parent polynucleotide sequence | Chemistry; Metallurgy | 4 | Expired |
| US10239949B2 | Oncofetal antigen binding proteins and related compositions and methods | Chemistry; Metallurgy | 4 | Active |
| US10689454B2 | Anti-CD137 antibodies and uses thereof | Physics | 3 | Active |
| US7081513B2 | Nucleic acids encoding (poly) peptides having chips activity | Emerging Cross-Sectional Technologies | 3 | Expired |
| US7282334B2 | Method for in vitro molecular evolution of protein function | Chemistry; Metallurgy | 3 | Expired |
| US11008396B2 | Polypeptides | Chemistry; Metallurgy | 2 | Active |
| US7388078B2 | Nucleic acids encoding polypeptides having chips activity | Emerging Cross-Sectional Technologies | 2 | Expired |
| US7262012B2 | Method for in vitro molecular evolution of protein function using varied exonuclease digestion in two polynucleotide populations | Chemistry; Metallurgy | 1 | Expired |
| US7563578B2 | Method for in vitro molecular evolution of protein function | Chemistry; Metallurgy | 1 | Active |
| US11312786B2 | Oncofetal antigen binding proteins and related compositions and methods | Chemistry; Metallurgy | 1 | Active |
| US11873348B2 | Peptides | Chemistry; Metallurgy | 1 | Active |
| US7662551B2 | Synthesis of hybrid polynucleotide molecules using single-stranded polynucleotide molecules | Chemistry; Metallurgy | 1 | Expired |
| US12173082B2 | Bispecific polypeptides against CD137 | Chemistry; Metallurgy | 0 | Active |
| US9834589B2 | CD86 variants with improved affinity for CTLA-4 | Physics | 0 | Active |
| US11780928B2 | Polypeptides | Chemistry; Metallurgy | 0 | Active |
| US11149090B2 | Combination therapies with anti CD40 antibodies | Chemistry; Metallurgy | 0 | Active |
| US8552149B2 | Polypeptides and use thereof | Human Necessities | 0 | Active |
| US12415862B2 | Methods and compositions | Chemistry; Metallurgy | 0 | Active |
| US8685640B2 | Medical methods and agents for use therein | Physics | 0 | Active |
| US8071289B2 | Synthesis of hybrid polynucleotide molecules using single-stranded polynucleotide molecules | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.